Pulmonary & Sleep Consultants

Personal and Professional Pulmonary & Sleep services in South Florida

  • Home
  • Services
    • Pulmonary Medicine
    • Obstructive Sleep Apnea (OSA)
    • Lung nodules
  • Our Doctors
    • J.J. Rajter MD
    • Juliana Cepelowicz Rajter, MD
  • Contact Us
  • Resources
    • Instructions
    • Post a review
    • Hospital Affiliations
  • Blog
  • Patient Portal

Pulmonary Hypertension

Understanding Pulmonary Hypertension

Pulmonary Arterial Hypertension (PAH) is a serious, progressive condition where the small arteries in the lungs become stiff, thickened, and narrow, creating a “traffic jam” for blood flow. Because these lung “pipes” are constricted, the right side of the heart must work significantly harder to pump blood through to pick up oxygen, much like trying to force liquid through a thin, clogged straw. Over time, this constant straining causes the heart muscle to weaken and enlarge, leading to symptoms like severe shortness of breath, fatigue, and dizziness. Unlike typical high blood pressure measured with an arm cuff, PAH specifically targets the heart-lung connection and requires specialized medical care to help dilate the vessels and reduce the workload on the heart.

Common Symptoms

  • Shortness of Breath: Especially during exercise or daily activities.
  • Fatigue: Feeling unusually tired or weak.
  • Dizziness: Lightheadedness or fainting (syncope).
  • Chest Pain: Pressure or tightness.
  • Swelling: Edema in the ankles, legs, or abdomen.

Pulmonary Hypertension Diagnostic Journey

Diagnosing Pulmonary Arterial Hypertension (PAH) requires a systematic “rule-out” process to ensure the correct cause is treated.

Phase 1: Initial Screening (The Suspicion)

Most journeys begin with unexplained shortness of breath. The first goal is to see if the heart is under stress.

  • Echocardiogram: Non-invasive Uses sound waves to estimate lung pressure and see if the right side of the heart is enlarged.
  • ECG/EKG: Checks for electrical signs of heart strain.

Phase 2: Ruling Out Common Causes

PH is often a “side effect” of other diseases. These tests check if the lungs or left heart are the primary culprits.

  • Pulmonary Function Tests (PFTs): Checks for asthma, COPD, or scarring (Group 3).
  • V/Q Scan: A critical nuclear medicine scan to rule out old blood clots (Group 4/CTEPH).
  • Blood Tests: Screening for Lupus, Scleroderma, HIV, and Liver function (Group 1 associated).

Phase 3: Confirmation & Hemodynamics

  • If Group 1 PAH is suspected, an invasive test is required to confirm the pressure readings and guide therapy.
  • Right Heart Catheterization (RHC)
    A specialist threads a small tube into the heart to directly measure:
      • mPAP: Mean Pulmonary Artery Pressure (Must be > 20 mmHg).
      • PVR: Pulmonary Vascular Resistance (Must be > 3 Woods Units).
      • PCWP: Wedge Pressure (Must be ≤ 15 mmHg to confirm it’s not a left-heart issue).
      • Vasoreactivity: Testing if inhaled gas (Nitric Oxide) can relax the vessels immediately.

Classification by Cause (WHO Groups)

Doctors categorize PH into five groups to determine the best treatment approach:

Group Category Common Causes
Group 1 PAH Genetic, idiopathic, or linked to Lupus/HIV.
Group 2 Left Heart Disease Heart failure or valve problems.
Group 3 Lung Disease COPD, Emphysema, or Sleep Apnea.
Group 4 CTEPH Chronic blood clots in the lungs.
Group 5 Other Rare disorders like sarcoidosis.

Functional Severity Classes

This scale helps your doctor understand how PH affects your daily life:

  • Class I: Normal activity causes no symptoms.
  • Class II: Comfortable at rest; ordinary activity causes symptoms.
  • Class III: Comfortable at rest; minimal activity causes symptoms.
  • Class IV: Symptoms are present even while resting.

Treatment & Management

  • Medications: Specific drugs to relax lung vessels (vasodilators) or remove fluid (diuretics).
  • Oxygen Therapy: To reduce the workload on your heart.
  • Lifestyle: Low-sodium diet, smoking cessation, and light, supervised exercise.
  • Surgery: Procedures to remove clots (for Group 4) or lung transplantation in severe cases.

Recent Posts

  • Dr. Rajter’s opening statement to US Senate Homeland Security Hearing on early treatment for COVID-19.
  • Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
  • Chest Journal. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019
  • Chest Journal Club Webinar. Icon Study: Use of Ivermectin in Hospitalized Patients With COVID-19.

Contact Info

Pulmonary and Sleep Consultants
1001 S. Andrews Ave
Suite 100
Fort Lauderdale, FL 33316

Tel. 954-906-6000
Fax. 954-860-7650

Connect with us

  • Facebook
  • Twitter

Copyright © 2026 Pulmonary and Sleep Consultants     ·     Built by MySalesButler.com, LLC

 

Loading Comments...